A novel effort from Microsoft and Adaptive Biotechnologies to diagnose multiple diseases from a single blood test is a data challenge on the scale of Google search. “Google categorized the… Read More
Adaptive Biotechnologies signed a deal with Illumina, the largest genetic sequencing firm in the U.S., to produce kits that can read the human immune system to detect diseases at labs… Read More
Follow-up: Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company The public market is bullish on Adaptive Biotechnologies. The biotech company started trading on the… Read More
Adaptive Biotechnologies, a high-flying startup that makes technology to read the human immune system, has officially filed to go public and seeks to raise $230 million from investors. Founded in… Read More
As the CEO of Adaptive Biotechnologies, Chad Robins has shown a knack for turning really good ideas into a viable business. But even Robins admits that he makes for an… Read More